An open-label observation study of topiramate administration as adjuvant therapy for focal epilepsy, Lennox-Gastaut syndrome epileptic seizures and generalized tonoclonic seizures in adults and children aged 2 years and older.
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy; Lennox-Gastaut syndrome; Tonic-clonic epilepsy
- Focus Adverse reactions
- Sponsors Janssen-Cilag
- 19 Oct 2007 Status changed from in progress to completed.
- 05 Nov 2006 New trial record.